[go: up one dir, main page]

WO2009071098A3 - Utilisation d'un mammifère non humain capable de transpirer pour déterminer l'effet de médicaments induisant une hypothermie chez les êtres humains - Google Patents

Utilisation d'un mammifère non humain capable de transpirer pour déterminer l'effet de médicaments induisant une hypothermie chez les êtres humains Download PDF

Info

Publication number
WO2009071098A3
WO2009071098A3 PCT/DK2008/050296 DK2008050296W WO2009071098A3 WO 2009071098 A3 WO2009071098 A3 WO 2009071098A3 DK 2008050296 W DK2008050296 W DK 2008050296W WO 2009071098 A3 WO2009071098 A3 WO 2009071098A3
Authority
WO
WIPO (PCT)
Prior art keywords
effect
perspiration
determining
humans
human mammal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/DK2008/050296
Other languages
English (en)
Other versions
WO2009071098A2 (fr
Inventor
Jacob Gotfredsen
Uno Jakob Weber
Malene Weis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NEUROKEY AS
Original Assignee
NEUROKEY AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NEUROKEY AS filed Critical NEUROKEY AS
Publication of WO2009071098A2 publication Critical patent/WO2009071098A2/fr
Publication of WO2009071098A3 publication Critical patent/WO2009071098A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pathology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

L'invention concerne un procédé pour déterminer l'effet d'un composé pour induire une hypothermie chez un être humain par utilisation d'un mammifère non humain capable de transpirer, ledit mammifère présentant de préférence un poids corporel comparable à celui de l'être humain sur lequel on étudie les effets.
PCT/DK2008/050296 2007-12-05 2008-12-05 Utilisation d'un mammifère non humain capable de transpirer pour déterminer l'effet de médicaments induisant une hypothermie chez les êtres humains Ceased WO2009071098A2 (fr)

Applications Claiming Priority (30)

Application Number Priority Date Filing Date Title
DKPA200701745 2007-12-05
DKPA200701743 2007-12-05
DKPA200701744 2007-12-05
DKPA200701743 2007-12-05
DKPA200701742 2007-12-05
DKPA200701742 2007-12-05
DKPA200701745 2007-12-05
DKPA200701744 2007-12-05
DKPA200800498 2008-04-04
DKPA200800498 2008-04-04
DKPA200800519 2008-04-09
DKPA200800515 2008-04-09
DKPA200800519 2008-04-09
DKPA200800515 2008-04-09
DKPA200800520 2008-04-09
DKPA200800520 2008-04-09
DKPA200800716 2008-05-23
DKPA200800716 2008-05-23
DKPA200801105 2008-08-15
DKPA200801104 2008-08-15
DKPA200801105 2008-08-15
DKPA200801104 2008-08-15
DKPA200801135 2008-08-21
DKPA200801134 2008-08-21
DKPA200801141 2008-08-21
DKPA200801134 2008-08-21
DKPA200801141 2008-08-21
DKPA200801135 2008-08-21
DKPA200801337 2008-09-26
DKPA200801337 2008-09-26

Publications (2)

Publication Number Publication Date
WO2009071098A2 WO2009071098A2 (fr) 2009-06-11
WO2009071098A3 true WO2009071098A3 (fr) 2009-07-23

Family

ID=40672557

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DK2008/050296 Ceased WO2009071098A2 (fr) 2007-12-05 2008-12-05 Utilisation d'un mammifère non humain capable de transpirer pour déterminer l'effet de médicaments induisant une hypothermie chez les êtres humains

Country Status (1)

Country Link
WO (1) WO2009071098A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2155300A1 (fr) 2007-04-05 2010-02-24 Velomedix, Inc Système de thérapie automatisé et procédé associé
CA2693774A1 (fr) 2007-07-09 2009-01-15 Velomedix, Inc. Dispositifs et procedes d'hypothermie
US9622670B2 (en) 2010-07-09 2017-04-18 Potrero Medical, Inc. Method and apparatus for pressure measurement

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CHAI C Y ET AL: "HYPOTHERMIC ACTION OF CHLORPROMAZINE IN MONKEYS", BRITISH JOURNAL OF PHARMACOLOGY, NATURE PUBLISHING GROUP, BASINGSTOKE, HANTS, vol. 57, 1 January 1976 (1976-01-01), pages 43 - 49, XP002932103, ISSN: 0007-1188 *
FORMAN D L ET AL: "A new approach to induced hypothermia", JOURNAL OF SURGICAL RESEARCH, ACADEMIC PRESS INC., SAN DIEGO, CA, US, vol. 40, no. 1, 1 January 1986 (1986-01-01), pages 36 - 42, XP023024717, ISSN: 0022-4804, [retrieved on 19860101] *
MALIK J K ET AL: "Effects of cholinesterase reactivators and atropine on fenitrothion-induced hypothermia in bubal us bubalis", TOXICOLOGY LETTERS, ELSEVIER BIOMEDICAL PRESS, AMSTERDAM, NL, vol. 36, no. 3, 1 May 1987 (1987-05-01), pages 289 - 295, XP023773881, ISSN: 0378-4274, [retrieved on 19870501] *
MATSUZAKI M ET AL: "DELTA<9>-Tetrahydrocannabinol: EEG changes, bradycardia and hypothermia in the rhesus monkey", BRAIN RESEARCH BULLETIN, ELSEVIER SCIENCE LTD, OXFORD, GB, vol. 19, no. 2, 1 August 1987 (1987-08-01), pages 223 - 229, XP024389037, ISSN: 0361-9230, [retrieved on 19870801] *

Also Published As

Publication number Publication date
WO2009071098A2 (fr) 2009-06-11

Similar Documents

Publication Publication Date Title
IL250435A0 (en) Using hil-2-mutein of human origin to prepare a factor for the production of regulatory t cells
EP2308459A4 (fr) Agent topique pour la peau du type huile dans l eau
ZA201304638B (en) Composition for use in the prevention and /or treatment of skin condition and skin diseases.
WO2011083150A3 (fr) Petites molécules pour traiter l&#39;obésité
IL210802A0 (en) Purin derivatives for use in the treatment of fab-related diseases
EP2424360A4 (fr) Utilisation topique, périoculaire ou intraoculaire de tocotriénols pour le traitement de maladies ophtalmiques
WO2013063391A3 (fr) Animaux transgéniques et leurs procédés d&#39;utilisation
WO2012006421A3 (fr) Diagnostic et traitement du cancer du sein
IL216967B (en) The history of 17-hydroxy-17-pentafluoroethyl-astra-9,4 (10)-diene-11-aryl and their use for the treatment of diseases
IL213351A0 (en) Methods for the preparation of fungicides
AU2012265069A1 (en) Compression bandage for placing on the human or animal body
PL2726470T3 (pl) Pochodne 1,2,4-tiadiazol-5-ilo piperazyny przydatne w leczeniu chorób neurodegeneracyjnych
PL2306816T3 (pl) Zastosowanie miejscowych kompozycji do konserwowania ludzkiego lub zwierzęcego ciała
IL200091A0 (en) Use of chitosans for the treatment of nail inflammatory diseases
EP2486925A4 (fr) Agent thérapeutique de l&#39;infarctus cérébral
GB201007011D0 (en) Methods and compositions for reversibly reducing the aural sensitivity of humans and animals
WO2009071098A3 (fr) Utilisation d&#39;un mammifère non humain capable de transpirer pour déterminer l&#39;effet de médicaments induisant une hypothermie chez les êtres humains
EP2157089A4 (fr) Utilisations thérapeutiques de dérivés d&#39;acide imidazol-5-carboxylique
WO2009053742A3 (fr) Nouveaux sels
ZA201101821B (en) 1-amino-alkylcyclohexane derivatives for the treatment of inflammatory skin deases
WO2012116992A3 (fr) Utilisation orale
GB201013829D0 (en) Human in vitro model of the blood cerebrospinal fluid barrier
IT1400089B1 (it) Composizione in polvere per la prevenzione e il trattamento delle patologie podali degli animali
AT506525A3 (de) Trainingsgerät für zumindest teile der rückenmuskulatur des menschlichen körpers
HUE040124T2 (hu) Diaminooxidázt tartalmazó helyi alkalmazású kompozíciók, magas hisztamin-szinttel társult, a fájdalom növekedésével járó betegségek kezelésére vagy megelõzésére

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 06.09.2010)

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08858286

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 08858286

Country of ref document: EP

Kind code of ref document: A2